Hubert Bigajski

Hubert Bigajski

Auto-generated profile, based on publicly available information

Hubert Bigajski

Department of Neurology, Student’s Scientific Association, Department of Neurology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
PJPaulina Jakubczyk
Paulina Jakubczyk
PWPiotr Widera
Piotr Widera
JHJustyna Helis
Justyna Helis
MMMaciej Michalik
Maciej Michalik
ABAleksandra Buczek
Aleksandra Buczek
MHMarta Handschuh
Marta Handschuh
Aim of the StudyThis review investigates the relationship between physical activity and inflammatory bowel disease (IBD), focusing on inflammatory markers, gut microbiota composition, and disease activity. The objective is to examine how exercise intensities influence inflammation, microbial diversity, and patient outcomes for IBD management. Materials and MethodsA literature review synthesized peer-reviewed studies from 2010-2024 using PubMed, Scopus, and Embase databases, examining physical activity effects on inflammatory markers, gut microbiota, and clinical outcomes in IBD patients. Inclusion criteria emphasized human studies, excluding research unrelated to IBD or focused on animal models. State of KnowledgeModerate-intensity aerobic and resistance exercises reduce systemic inflammatory markers, (CRP and cytokines) and enhance gut microbiota diversity, increasing anti-inflammatory species. Low-to-moderate intensity activities improve quality of life in IBD patients. Exercise supports intestinal barrier integrity through mucin production and fatty acid synthesis. High-intensity exercise can worsen inflammation, necessitating tailored protocols. ConclusionsPhysical activity is a promising adjunctive therapy in IBD management. Moderate-intensity programs effectively maintain remission and enhance outcomes. Future research should focus on longitudinal studies, advanced omics technologies, and combined approaches with dietary and pharmacological therapies.

14 January 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
HBHubert Bigajski
Hubert Bigajski
ABAleksandra Banaś
Aleksandra Banaś
MMMaciej Michalik
Maciej Michalik
PWPiotr Widera
Piotr Widera
MHMarta Handschuh
Marta Handschuh
ABAleksandra Buczek
Aleksandra Buczek
Introduction and Purpose This review explores physical activity's role in managing urological health, focusing on prostate cancer and overactive bladder (OAB). These conditions significantly affect quality of life globally. The review synthesizes research to identify gaps and propose future directions for clinical practice. Materials and Methods A literature search was conducted using PubMed, MEDLINE, and Cochrane Library databases (2010-2023). The focus was on randomized controlled trials, observational studies, and systematic reviews. Key terms included "physical activity," "prostate cancer," "overactive bladder," and "urological health." Studies were selected based on relevance to exercise interventions in urological conditions. Results High-intensity exercise reduces prostate cancer risk by 10–30% and improves outcomes by enhancing cardiovascular fitness and quality of life. For OAB, low-impact aerobic exercises alleviate symptoms by improving neuromuscular control and reducing inflammation. Mechanisms include hormonal regulation, improved metabolic health, and reduced inflammation. Structured prehabilitation programs with pelvic floor muscle training optimize continence outcomes post-surgery. Conclusions Physical activity is a cost-effective intervention for managing urological health. Despite strong evidence supporting its benefits, gaps remain in understanding optimal exercise prescriptions and long-term effects across diverse populations. Future research should focus on tailoring interventions to patient needs, exploring innovative modalities like high-intensity interval training, and integrating exercise with other treatments to improve outcomes.

20 April 2026 in Journal of Pre-Clinical and Clinical Research
Verified
Journal Article
Open access
PWPiotr Widera
Piotr Widera
HBHubert Bigajski
Hubert Bigajski
MMMaciej Michalik
Maciej Michalik
ABAleksandra Banaś
Aleksandra Banaś
DSDominika Sarna
Dominika Sarna
WLWiktoria Laskowska
Wiktoria Laskowska

17 July 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
HBHubert Bigajski
Hubert Bigajski
FBFilip Basta
Filip Basta
KMKatarzyna Mostowska
Katarzyna Mostowska
ATAlicja Tomasiak
Alicja Tomasiak
KGKrystian Głąbiński
Krystian Głąbiński
MWMichał WęGrzyn
Michał WęGrzyn
Background. For decades, the male urinary tract was considered sterile. Next-generation sequencing (NGS) overturned this dogma, revealing a complex urobiome. Aim. This study aims to summarize literature on the physiological male urobiome and evaluate the impact of its dysbiosis on the pathogenesis of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and benign prostatic hyperplasia (BPH). Material and methods. A narrative review was conducted using PubMed and Scopus, focusing on contemporary literature (2017–2025). Keywords included: male urobiome, urinary microbiome, chronic prostatitis, benign prostatic hyperplasia, dysbiosis. Case reports and animal models were excluded, prioritizing human clinical data and NGS-based analyses with rigorous negative controls. Results. The healthy male urobiome exhibits multi-species diversity (e.g., Corynebacterium, Streptococcus). In CP/CPPS, hidden dysbiosis replaces the sterility concept; anaerobic enrichment directly correlates with pain and inflammation. In BPH, dysbiosis acts as an inflammatory cofactor driving tissue growth. Urobiome destabilization is linked to metabolic syndrome and visceral obesity, generating systemic inflammation and exacerbating lower urinary tract symptoms (LUTS). Conclusions. Dysbiosis plays a pivotal role in CP/CPPS and BPH pathogenesis. Instead of ineffective empirical antibiotic therapy destroying commensal flora, modern strategies should rely on microbiome modulation (targeted probiotics) and biofilm eradication (bacteriophages for catheter infection prevention).

26 December 2025 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
ABAleksandra Banaś
Aleksandra Banaś
HBHubert Bigajski
Hubert Bigajski
SJSzymon Janczarski
Szymon Janczarski
KKKlaudia Kwolek
Klaudia Kwolek
WLWiktoria Laskowska
Wiktoria Laskowska
PWPiotr Widera
Piotr Widera
Continuous glucose monitoring (CGM) represents a paradigm shift in diabetes management, transitioning care from reactive monitoring to proactive glycemic control; however, its adoption remains stratified by deep-seated socioeconomic and structural, and technological inequities. This narrative review synthesizes literature published between 2017 and 2025 to evaluate the clinical efficacy of CGM while interrogating the socio-technical barriers shaping its accessibility. A thematic analysis of current evidence confirms that while CGM significantly improves HbA1c, quality of life, and hypoglycemia reduction across Type 1 and Type 2 diabetes, access to these outcomes is severely constrained by systemic and digital obstacles. Key findings identify a “coverage patchwork” wherein high out-of-pocket costs and administrative hurdles disproportionately restrict access for Medicaid beneficiaries and low-income populations. Furthermore, the review highlights persistent racial disparities driven by provider implicit bias, alongside a “digital divide” where limited connectivity and low eHealth literacy impede effective utilization. Consequently, without intervention, CGM risks functioning as an “accelerator of disparities,” creating a two-tier healthcare system that privileges “data-rich” early adopters while leaving marginalized groups behind. The authors conclude that bridging this gap requires a multifaceted strategy integrating policy reform, inclusive device design, and literacy-centered education to ensure technological innovation advances health equity rather than reinforcing the “Matthew Effect” in diabetes management.

2 March 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
PDF file
KKKlaudia Kwolek
Klaudia Kwolek
MPMarcel Pilarek
Marcel Pilarek
WLWiktoria Laskowska
Wiktoria Laskowska
HBHubert Bigajski
Hubert Bigajski
DSDominika Sarna
Dominika Sarna
HDHubert Dacyl
Hubert Dacyl
As chronic non-communicable diseases (NCDs) reach epidemic proportions globally, traditional episodic care models remain insufficient, necessitating a shift toward continuous, technology-driven management. This narrative review critically assesses the clinical utility of telemedicine interventions—specifically continuous glucose monitoring, remote hypertension surveillance, and implantable hemodynamic sensors—while examining the persistent socio-technical barriers impeding their widespread adoption. Based on a comprehensive synthesis of literature from PubMed/MEDLINE, Scopus, and Google Scholar (2020–2025), this study contrasts clinical efficacy with implementation realities. The evidence confirms that while telemedical tools consistently surpass conventional care in stabilizing metabolic control and lowering hospitalization rates, their long-term viability is compromised by the "Digital Divide 2.0"—a phenomenon defined by deficits in digital literacy and usability challenges among the elderly. Moreover, the analysis identifies systemic bottlenecks, including fragmented data standardization and the exclusion of patient-generated health data from routine workflows. Ethical tensions surrounding algorithmic paternalism and surveillance fatigue are also highlighted as critical factors affecting patient autonomy. Ultimately, bridging the gap between digital capability and sustainable practice requires moving beyond technological determinism toward a holistic strategy that integrates policy innovation, human-centered design, and ethical data governance.